{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:39:38Z","timestamp":1770694778085,"version":"3.49.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.det.2004.09.008","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T13:54:58Z","timestamp":1113486898000},"page":"227-243","source":"Crossref","is-referenced-by-count":65,"title":["Management of Hair Loss"],"prefix":"10.1016","volume":"23","author":[{"given":"Elizabeth K.","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2004.09.008_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","article-title":"Recommended guidelines for the evaluation and treatment of male and female pattern hair loss","volume":"52","author":"Olsen","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0190-9622(99)70006-X","article-title":"Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment","volume":"41","author":"Price","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0190-9622(98)70007-6","article-title":"Finasteride in the treatment of men with androgenetic alopecia","volume":"39","author":"Kaufman","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0190-9622(99)70081-2","article-title":"Finasteride in the treatment of men with frontal male pattern hair loss","volume":"40","author":"Leyden","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib6","first-page":"38","article-title":"Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia","volume":"12","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib7","first-page":"150","article-title":"Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss","volume":"13","author":"Whiting","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib8","unstructured":"Olsen E.A., Shapiro J. Managing the patient with androgenetic alopecia: current concepts in diagnosis and treatment (slides and lecture notes). Presented at the Rogaine Speakers Bureau, Pharmacia Corporation, 2001"},{"key":"10.1016\/j.det.2004.09.008_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1067\/mjd.2002.119104","article-title":"Allergic contact dermatitis to topical minoxidil solution: etiology and treatment","volume":"46","author":"Friedman","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10227-002-0121-6","article-title":"Safety of topical minoxidil solution: a one-year, prospective, observational study","volume":"7","author":"Shapiro","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.det.2004.09.008_bib11","unstructured":"Monograph on Proscar. Merck & Co., Inc: Whitehouse Station (NJ); April 2004"},{"issue":"11","key":"10.1016\/j.det.2004.09.008_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM199609123351116","article-title":"Gynecomastia and breast cancer during finasteride therapy","volume":"335","author":"Green","year":"1996","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.det.2004.09.008_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.det.2004.09.008_bib14","unstructured":"Monograph on Propecia. Merck & Co., Inc: Whitehouse Station (NJ); October 2003"},{"issue":"2","key":"10.1016\/j.det.2004.09.008_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/jc.74.2.345","article-title":"Hair growth effects of oral administration of finasteride, a steroid 5\u03b1-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque","volume":"74","author":"Diani","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.det.2004.09.008_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1346-8138.2002.tb00314.x","article-title":"Comparative efficacy of various treatment regimens for androgenetic alopecia in men","volume":"29","author":"Khandpur","year":"2002","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2004.09.008_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00003495-200161010-00006","article-title":"Treatments for androgenetic alopecia and alopecia areata: current options and future prospects","volume":"61","author":"Meidan","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.det.2004.09.008_bib18","series-title":"Disorders of hair growth: diagnosis and treatment","first-page":"321","article-title":"Pattern hair loss in men and women","author":"Olsen","year":"2003"},{"key":"10.1016\/j.det.2004.09.008_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000017954","article-title":"Ketoconazole shampoo: effect of long-term use in androgenic alopecia","volume":"196","author":"Pi\u00e9rard-Franchimont","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2004.09.008_bib20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0190-9622(86)80024-X","article-title":"Topical tretinoin for hair growth promotion","volume":"15","author":"Bazzano","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib21","series-title":"Hair loss: principles of diagnosis and management of alopecia","first-page":"83","article-title":"Androgenetic alopecia: pathogenesis, clinical features and practical medical treatment","author":"Shapiro","year":"2002"},{"key":"10.1016\/j.det.2004.09.008_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1523-1747.2003.12540.x","article-title":"Decreased serum ferritin is associated with alopecia in women","volume":"121","author":"Kantor","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archderm.139.9.1221","article-title":"Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal","volume":"139","author":"Tosti","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib24","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1524-4725.2002.02068.x","article-title":"The potential role of minoxidil in the hair transplantation setting","volume":"28","author":"Avram","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2004.09.008_bib25","first-page":"115","article-title":"Androgenetic alopecia in adolescents","volume":"71","author":"Price","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.det.2004.09.008_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archderm.1994.01690030035005","article-title":"Androgenetic alopecia in the female","volume":"130","author":"DeVillez","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1468-3083.2003.00621.x","article-title":"Hypertrichosis in females applying minoxidil topical solution and in normal controls","volume":"17","author":"Dawber","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2004.09.008_bib29","series-title":"Disorders of hair growth: diagnosis and treatment","first-page":"303","article-title":"Diffuse alopecia: telogen hair loss","author":"Fiedler","year":"2003"},{"key":"10.1016\/j.det.2004.09.008_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.286.5.527","article-title":"New oral contraceptive","volume":"286","author":"Schwetz","year":"2001","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.det.2004.09.008_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progestogens with antiandrogenic properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.det.2004.09.008_bib32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(02)04551-X","article-title":"Treatment of hyperandrogenic alopecia in women","volume":"79","author":"Carmina","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.det.2004.09.008_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2174\/1381612805666230111201150","article-title":"Current aspects of antiandrogen therapy in women","volume":"5","author":"Diamanti-Kandarakis","year":"1999","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.det.2004.09.008_bib35","series-title":"Comprehensive dermatologic drug therapy","first-page":"385","article-title":"Antiandrogens and androgen inhibitors","author":"Sawaya","year":"2001"},{"key":"10.1016\/j.det.2004.09.008_bib36","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1067\/mjd.2000.107953","article-title":"Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia","volume":"43","author":"Price","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1046\/j.1365-2133.2002.49084.x","article-title":"Finasteride for female androgenetic alopecia","volume":"147","author":"Thai","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1067\/mjd.2002.124608","article-title":"Hair loss in women with hyperandrogenism: four cases responding to finasteride","volume":"47","author":"Shum","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.09.008_bib39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4158\/EP.7.2.120","article-title":"American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders","volume":"7","author":"Goodman","year":"2001","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.det.2004.09.008_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0015-0282(03)00733-7","article-title":"What are the key features of importance in polycystic ovary syndrome?","volume":"80","author":"Lobo","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.det.2004.09.008_bib41","series-title":"Hair loss: principles of diagnosis and management of alopecia","first-page":"121","article-title":"Telogen effluvium: acute and chronic","author":"Shapiro","year":"2002"},{"key":"10.1016\/j.det.2004.09.008_bib42","first-page":"187","article-title":"Telogen effluvium after allergic contact dermatitis of the scalp","volume":"137","author":"Tosti","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(96)90113-9","article-title":"Chronic telogen effluvium: increased scalp hair shedding in middle-aged women","volume":"35","author":"Whiting","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2340\/0001555549180188","article-title":"Alopecia areata. A follow-up investigation of outpatient material","volume":"49","author":"Gip","year":"1969","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/j.det.2004.09.008_bib45","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2133.2003.05535.x","article-title":"Guidelines for the management of alopecia areata","volume":"149","author":"MacDonald Hull","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib46","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-4362.2003.01862.x","article-title":"Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial","volume":"42","author":"Mancuso","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib47","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archderm.136.10.1276","article-title":"Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream","volume":"136","author":"Charuwichitratana","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib48","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archderm.1972.01620150098034","article-title":"Treatment of alopecia areata with steroid solution","volume":"106","author":"Leyden","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000252466","article-title":"Assay of 0.2 percent fluocinolone acetonide cream for alopecia areata and totalis","volume":"141","author":"Pascher","year":"1970","journal-title":"Dermatologica"},{"key":"10.1016\/j.det.2004.09.008_bib50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mjd.2003.423","article-title":"Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis\/universalis","volume":"49","author":"Tosti","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib51","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archderm.1960.01580060048005","article-title":"Local injection of steroids and hair regrowth in alopecias","volume":"82","author":"Orentreich","year":"1960","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2133.1971.tb07230.x","article-title":"A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata","volume":"85","author":"Porter","year":"1971","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2133.1973.tb06672.x","article-title":"Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector","volume":"88","author":"Abell","year":"1973","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib54","first-page":"674","article-title":"Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs","volume":"71","author":"Kubeyinje","year":"1994","journal-title":"East Afr Med J"},{"key":"10.1016\/j.det.2004.09.008_bib55","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/archderm.134.9.1163","article-title":"Anaphylaxis to intradermal triamcinolone acetonide","volume":"134","author":"Downs","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archderm.1974.01630110027005","article-title":"Cutaneous corticosteroid injection and amaurosis. Analysis for cause and prevention","volume":"110","author":"Selmanowitz","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00455378","article-title":"Long-term intramuscular triamcinolone acetonide therapy in alopecia areata totalis and universalis","volume":"261","author":"Michalowski","year":"1978","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2004.09.008_bib58","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","article-title":"Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients","volume":"39","author":"Friedli","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib60","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2340\/000155555493496","article-title":"Large doses of glucocorticoid in the treatment of alopecia areata","volume":"55","author":"Burton","year":"1975","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/j.det.2004.09.008_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000051634","article-title":"High-dose pulse corticosteroid therapy: is it indicated for severe alopecia areata?","volume":"202","author":"Friedli","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2004.09.008_bib62","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0190-9622(87)70244-8","article-title":"Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay","volume":"17","author":"Wilkerson","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib63","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000250380","article-title":"Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester","volume":"161","author":"Happle","year":"1980","journal-title":"Dermatologica"},{"key":"10.1016\/j.det.2004.09.008_bib64","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","article-title":"Efficacy of topical sensitizers in the treatment of alopecia areata","volume":"39","author":"Rokhsar","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib65","first-page":"1063","article-title":"Predictive model for immunotherapy of alopecia areata with diphencyprone","volume":"137","author":"Wiseman","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(91)70032-W","article-title":"Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone","volume":"24","author":"van der Steen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-4362.1996.tb01618.x","article-title":"Treatment of alopecia areata with squaric acid dibutylester","volume":"35","author":"Micali","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1525-1470.1994.tb00078.x","article-title":"Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients","volume":"11","author":"Orecchia","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib69","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2133.1996.tb03835.x","article-title":"Alopecia areata in children: treatment with diphencyprone","volume":"135","author":"Schuttelaar","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0190-9622(86)70158-8","article-title":"Therapies versus placebo in the treatment of patchy alopecia areata","volume":"15","author":"Tosti","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0190-9622(96)90323-0","article-title":"Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis","volume":"35","author":"Tosti","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib72","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0738-081X(02)00272-9","article-title":"Topical immunotherapy: unapproved uses, dosages, or indications","volume":"20","author":"Higgins","year":"2002","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib73","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2133.1991.tb00643.x","article-title":"Alopecia areata and topical sensitizers: allergic response is necessary but irritation is not","volume":"124","author":"Orecchia","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib74","series-title":"Hair loss: principles of diagnosis and management of alopecia","first-page":"19","article-title":"Alopecia areata: pathogenesis, clinical features, diagnosis and practical management","author":"Shapiro","year":"2002"},{"key":"10.1016\/j.det.2004.09.008_bib75","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archderm.139.4.544","article-title":"Lentiginous eruption due to topical immunotherapy","volume":"139","author":"Tosti","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib76","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/archderm.1979.04010100058026","article-title":"Treatment of alopecia areata by anthralin-induced dermatitis","volume":"115","author":"Schmoeckel","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib77","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-4362.1985.tb05589.x","article-title":"Anthralin therapy for alopecia areata","volume":"24","author":"Nelson","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib78","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archderm.1987.01660350091020","article-title":"Evaluation of anthralin in the treatment of alopecia areata","volume":"123","author":"Fiedler-Weiss","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib79","first-page":"141","article-title":"Treatment of alopecia areata with three different PUVA modalities","volume":"1","author":"Lassus","year":"1984","journal-title":"Photodermatology"},{"key":"10.1016\/j.det.2004.09.008_bib80","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2133.1993.tb03309.x","article-title":"PUVA treatment for alopecia areata\u2014does it work? A retrospective review of 102 cases","volume":"129","author":"Healy","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib81","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2133.1995.tb06925.x","article-title":"PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology","volume":"133","author":"Taylor","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1440-0960.2003.00654.x","article-title":"PUVA treatment of alopecia areata totalis and universalis: a retrospective study","volume":"44","author":"Whitmont","year":"2003","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib83","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/bmj.287.6398.1015","article-title":"Topical minoxidil in the treatment of alopecia areata","volume":"287","author":"Fenton","year":"1983","journal-title":"BMJ"},{"key":"10.1016\/j.det.2004.09.008_bib84","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2340\/0001555566179180","article-title":"A trial of 1% minoxidil used topically for severe alopecia areata","volume":"66","author":"Vestey","year":"1986","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/j.det.2004.09.008_bib85","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0190-9622(87)70095-4","article-title":"Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata","volume":"16","author":"Price","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib86","first-page":"431","article-title":"3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata","volume":"41","author":"Fransway","year":"1988","journal-title":"Cutis"},{"key":"10.1016\/j.det.2004.09.008_bib87","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3949\/ccjm.56.2.149","article-title":"Extensive alopecia areata. Results of treatment with 3% topical minoxidil","volume":"56","author":"Ranchoff","year":"1989","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.det.2004.09.008_bib88","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archderm.1986.01660140070020","article-title":"Topical minoxidil dose-response effect in alopecia areata","volume":"122","author":"Fiedler-Weiss","year":"1986","journal-title":"Arch Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.det.2004.09.008_bib89","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000248901","article-title":"Topical minoxidil in extensive alopecia areata, including 3-year follow-up","volume":"175","author":"Price","year":"1987","journal-title":"Dermatologica"},{"key":"10.1016\/j.det.2004.09.008_bib90","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.288.6419.794-a","article-title":"Topical minoxidil in the treatment of alopecia areata","volume":"288","author":"Maitland","year":"1984","journal-title":"BMJ"},{"key":"10.1016\/j.det.2004.09.008_bib91","doi-asserted-by":"crossref","first-page":"69S","DOI":"10.1111\/1523-1747.ep12471880","article-title":"Alopecia areata: current therapy","volume":"96","author":"Fiedler","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib92","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1038\/jid.1995.54","article-title":"Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation","volume":"104","author":"Shapiro","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2004.09.008_bib93","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archderm.1990.01670300056006","article-title":"Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin","volume":"126","author":"Fiedler","year":"1990","journal-title":"Arch Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863504000944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863504000944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T22:03:18Z","timestamp":1706133798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863504000944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0733863504000944"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2004.09.008","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}